RISK FACTORS FOR SEVERE COVID-19 INFECTION AMONG PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (AIRD) AND THE IMPACT OF VACCINATIONS - AN ISRAELI, MULTI-CENTER EXPERIENCE

被引:0
|
作者
Kharouf, F. [1 ]
Eviatar, T. [2 ]
Braun, M. [3 ]
Pokroy-Shapira, E. [4 ]
Brodavka, M. [5 ]
Agmon-Levin, N. [6 ]
Toledano, K. [7 ]
Oren, S. [4 ]
Lidar, M. [5 ]
Vazina, M. Amit [8 ]
Sabbah, F. [9 ]
Tavor, Y. [7 ]
Breuer, G. [10 ]
Zisman, D. [11 ]
Markovits, D. [7 ]
Dagan, A. [12 ]
Garzuzi, R. Bishara [11 ]
Shifman, O. [13 ]
Giryes, S. [7 ]
Elias, M. [11 ]
Feld, J. [11 ]
Reitblat, T. [14 ]
Gazit, T. [11 ]
Hadad, A. [11 ]
Elkayam, O. [2 ]
Paran, D. [2 ]
Mevorach, D. [1 ]
Balbir-Gurman, A. [7 ]
Braun-Moscovici, Y. [7 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Rheumatol, Jerusalem, Israel
[2] Tel Aviv Univ, Inst Rheumatol, Sackler Sch Med, Tel Aviv Med Ctr, Tel Aviv, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Ctr, Bioinformat, Jerusalem, Israel
[4] Tel Aviv Univ, Inst Rheumatol, Sackler Sch Med, Beilinson Hosp, Petah Tiqwa, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Rheumatol Unit, Sheba Med Ctr, Tel Hashomer, Israel
[6] Tel Aviv Univ, Sackler Sch Med, Sheba Med Ctr, Allergy & Clin Immunol Unit, Tel Hashomer, Israel
[7] Technion Israel Inst Technol, Rambam Hlth Care Campus, Rappaport Fac Med, Inst Rheumatol, Haifa, Israel
[8] Tel Aviv Univ, Sackler Sch Med, Shamir Med Ctr, Rheumatol, Rishon Le Tsiyon, Israel
[9] Baruch Padeh Med Ctr, Rheumatol, Poriya, Tiberias, Israel
[10] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Rheumatol, Jerusalem, Israel
[11] Technion Israel Inst Technol, Carmel Med Ctr, Rappaport Fac Med, Rheumatol, Haifa, Israel
[12] Ben Gurion Univ Negev, Assuta Ashdod Med Ctr, Rheumatol, Ashdod, Israel
[13] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Rheumatol Serv, Kefar Sava, Israel
[14] Ben Gurion Univ Negev, Barzilai Med Ctr, Rheumatol, Ashqelon, Israel
关键词
D O I
10.1136/annrheumdis-2022-eular.3679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1254
引用
收藏
页码:962 / 962
页数:1
相关论文
共 50 条
  • [21] Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
    Zheng, Yi-Qing
    Li, He-Jun
    Chen, Ling
    Lin, Shun-Ping
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] Immunogenicity of COVID-19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Diseases (AIIRDs)
    Lam, Gordon
    Laster, Andrew
    McCarter, Sarah
    Gladue, Heather
    Kashif, Ahmad
    Siceloff, Erin
    Lackey, Victoria
    Robertson, Cheryl
    Toci, Ashley
    Calabrese, Leonard
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2013 - 2016
  • [23] Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
    Yi-Qing Zheng
    He-Jun Li
    Ling Chen
    Shun-Ping Lin
    Scientific Reports, 12
  • [24] Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland
    McKeigue, P. M.
    Porter, D.
    Hollick, R. J.
    Ralston, S. H.
    McAllister, D. A.
    Colhoun, H. M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, : 412 - 417
  • [25] Incidence and Risk Factors for Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients with Systemic Autoimmune Rheumatic Diseases
    Kawano, Yumeko
    Wang, Xiaosong
    Patel, Naomi
    Qian, Grace
    Kowalski, Emily
    Bade, Katarina
    Vanni, Kathleen
    Williams, Zachary
    Cook, Claire
    Srivatsan, Shruthi
    Wallace, Zachary
    Sparks, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 423 - 425
  • [26] SEVERE COVID-19 OUTCOMES AMONG PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: A POPULATION-BASED STUDY
    Marozoff, S.
    Fazal, Z. A.
    Tan, J.
    Lu, N.
    Hoens, A.
    Lacaille, D.
    Kopec, J.
    Xie, H.
    Loree, J. M.
    Esdaile, J.
    Avina-Zubieta, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 162 - 163
  • [27] RISK FACTORS AND OUTCOMES OF AUTOIMMUNE/INFLAMMATORY DISEASES DURING COVID-19 INFECTION: A COMPARATIVE STUDY
    Vera-Lastra, Olga
    Cime-Ake, Erik
    Eduardo Morales-Gutierrez, Joel
    De Jesus Cobos-Quevedo, Orestes
    Ordinola-Navarro, Alberto
    Lilia Peralta-Amaro, Ana
    Pilar Cruz-Dominguez, Maria
    Medina, Gabriela
    Fraga-Mouret, Antonio
    Jara, Luis J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S61 - S62
  • [28] COVID-19 INFECTION IN PATIENTS WITH RHEUMATIC DISEASES: TWO CENTERS EXPERIENCE
    Sahin, A.
    Gedikli, M. A.
    Derin, M. E.
    Karakas, B.
    Karatas, B.
    Celik, N. Cabuk
    Yalcin, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1380 - 1380
  • [29] COVID-19 Vaccination Status and Adverse Events Following SARS-CoV-2 Vaccine in Autoimmune Inflammatory Rheumatic Disease (AIRD) Patients: A Single Center Experience
    Luceno, Vincent
    Daleon, Peter Paolo
    Navarra, Sandra
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2240 - 2242
  • [30] CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
    Chevalier, Kevin
    Genin, Michael
    Jean, Thomas Petit
    Avouac, Jerome
    Flipo, Rene-Marc
    Georgin-Lavialle, Sophie
    El Mahou, Soumaya
    Pertuiset, Edouard
    Pham, Thao
    Servettaz, Amelie
    Marotte, Hubert
    Domont, Fanny
    Chazerain, Pascal
    Devaux, Mathilde
    Mekinian, Arsene
    Sellam, Jeremie
    Fautrel, Bruno
    Rouzaud, Diane
    Ebstein, Esther
    Costedoat-Chalumeau, Nathalie
    Richez, Christophe
    Hachulla, Eric
    Mariette, Xavier
    Seror, Raphaele
    FRONTIERS IN MEDICINE, 2023, 10